Abstract
Clotrimazole is an antimycotic imidazole derivative that interferes with cellular Ca2+ homeostasis. We investigated the effects of clotrimazole on acute lymphoblastic leukemia (ALL) cells. Treatment with 10 μM clotrimazole (a concentration achievable in vivo) reduced cell recovery from cultures of all nine ALL cell lines studied (B-lineage: OP-1, SUP-B15, RS4;11, NALM6, REH, and 380; T-lineage: MOLT4, CCRF-CEM, and CEM-C7). After 4 days of culture, median cell recovery was 10% (range, <1% to 37%) of cell recovery in parallel untreated cultures. Clotrimazole also inhibited recovery of primary ALL cells cultured on stromal feeder layers. After leukemic cells from 16 cases of ALL were cultured for 7 days with 10 μM clotrimazole, median cell recovery was <1% (range, <1% to 16%) of that in parallel untreated cultures. Clotrimazole was active against leukemic cells with genetic abnormalities associated with poor response to therapy and against multidrug-resistant cell lines. In contrast, mature T lymphocytes and bone marrow stromal cells were not affected. Clotrimazole induced depletion of intracellular Ca2+ stores in ALL cells, which was followed by apoptosis, as shown by annexin V binding and DNA fragmentation. Thus, clotrimazole is cytotoxic to ALL cells at concentrations achievable in vivo.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pui CH, Campana D, Evans WE . Childhood acute lymphoblastic leukemia – current status and future perspectives Lancet Oncology 2001 2: 597–607
Kantarjian HM, O'Brien S, Smith TL, Cortes J, Giles FJ, Beran M, Pierce S, Huh Y, Andreeff M, Koller C, Ha CS, Keating MJ, Murphy S, Freireich EJ . Results of treatment with hyper-CVAD, adose-intensive regimen, in adult acute lymphocytic leukemia J Clin Oncol 2000 18: 547–561
Berridge MJ . Inositol trisphosphate and calcium signalling Nature 1993 361: 315–325
Clapham DE . Calcium signaling Cell 1995 80: 259–268
Lewis RS . Calcium signaling mechanisms in T lymphocytes Annu Rev Immunol 2001 19: 497–521
Fasolato C, Innocenti B, Pozzan T . Receptor-activated Ca2+ influx: how many mechanisms for how many channels? Trends Pharmacol Sci 1994 15: 77–83
Ishii TM, Silvia C, Hirschberg B, Bond CT, Adelman JP, Maylie J . A human intermediate conductance calcium-activated potassium channel Proc Natl Acad Sci USA 1997 94: 11651–11656
Joiner WJ, Wang LY, Tang MD, Kaczmarek LK . hSK4, a member of a novel subfamily of calcium-activated potassium channels Proc Natl Acad Sci USA 1997 94: 11013–11018
Logsdon NJ, Kang J, Togo JA, Christian EP, Aiyar J . A novel gene, hKCa4, encodes the calcium-activated potassium channel in human T lymphocytes J Biol Chem 1997 272: 32723–32726
Alvarez J, Montero M, Garcia-Sancho J . High affinity inhibition of Ca(2+)-dependent K+ channels by cytochrome P-450 inhibitors J Biol Chem 1992 267: 11789–11793
Hornstein EH, Vassilopoulos D, Thomas DE, Friedman FK, Tsokos GC . Modulation of human T-lymphocyte plasma membrane Ca2+ permeability by imidazole antimycotics Immunopharmacol Immunotoxicol 1996 18: 237–245
Aktas H, Fluckiger R, Acosta JA, Savage JM, Palakurthi SS, Halperin JA . Depletion of intracellular Ca2+ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of clotrimazole Proc Natl Acad Sci USA 1998 95: 8280–8285
Brugnara C, de Franceschi L, Alper SL . Inhibition of Ca(2+)-dependent K+ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives J Clin Invest 1993 92: 520–526
Rittenhouse AR, Vandorpe DH, Brugnara C, Alper SL . The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells J Membr Biol 1997 157: 177–191
Jensen BS, Odum N, Jorgensen NK, Christophersen P, Olesen SP . Inhibition of T cell proliferation by selective block of Ca(2+)-activated K(+) channels Proc Natl Acad Sci USA 1999 96: 10917–10921
Brugnara C, Gee B, Armsby CC, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt OS . Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease J Clin Invest 1996 97: 1227–1234
Brugnara C . Therapeutic strategies for prevention of sickle cell dehydration Blood Cells Mol Dis 2001 27: 71–80
Rufo PA, Merlin D, Riegler M, Ferguson-Maltzman MH, Dickinson BL, Brugnara C, Alper SL, Lencer WI . The antifungal antibiotic, clotrimazole, inhibits chloride secretion by human intestinal T84 cells via blockade of distinct basolateral K+ conductances. Demonstration of efficacy in intact rabbit colon and in an in vivo mouse model of cholera J Clin Invest 1997 100: 3111–3120
Benzaquen LR, Brugnara C, Byers HR, Gatton-Celli S, Halperin JA . Clotrimazole inhibits cell proliferation in vitro and in vivo Nat Med 1995 1: 534–540
Gow PJ, Corrigall V, Panayi GS . The effect of clotrimazole on human lymphocyte responsiveness to plant mitogens Agents Actions 1979 9: 543–548
Aussel C, Breittmayer JP, Ticchioni M, Pelassy C, Bernard A . Regulation of T cell activation by cytochrome P450 inhibitors Cell Immunol 1994 155: 436–445
Khanna R, Chang MC, Joiner WJ, Kaczmarek LK, Schlichter LC . hSK4/hIK1, a calmodulin-binding KCa channel in human T lymphocytes. Roles in proliferation and volume regulation J Biol Chem 1999 274: 14838–14849
Wojtulewski JA, Gow PJ, Walter J, Grahame R, Gibson T, Panayi GS, Mason J . Clotrimazole in rheumatoid arthritis Ann Rheum Dis 1980 39: 469–472
Dennison WB, Loeser RF, Turner RA, Johnson JA, Wells HB . A double blind placebo controlled trial of low dose clotrimazole in rheumatoid arthritis J Rheumatol 1990 17: 1003–1007
Weuta H . Clinical studies with oral clotrimazole Postgrad Med J 1974 50 (Suppl. 1): 45–48
Seo M, Iida H, Miura Y . Basic experiments with clotrimazole administered orally Curr Med Res Opin 1977 5: 169–178
Brugnara C, Armsby CC, Sakamoto M, Rifai N, Alper SL, Platt O . Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity J Pharmacol Exp Ther 1995 273: 266–272
Khalid MH, Shibata S, Hiura T . Effects of clotrimazole on the growth, morphological characteristics, and cisplatin sensitivity of human glioblastoma cells in vitro J Neurosurg 1999 90: 918–927
Smith MA, Zhang W, Naziruddin B, Cooper JD, Patterson GA, Mohanakumar T . Clotrimazole inhibits lung fibroblast proliferation in vitro: implications for use in the prevention and treatment of obliterative bronchiolitis after lung transplantation Transplantation 2000 70: 1263–1267
Stong RC, Korsmeyer SJ, Parkin JL, Arthur DC, Kersey JH . Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics Blood 1985 65: 21–31
Pegoraro L, Palumbo A, Erikson J, Falda M, Giovanazzo B, Emanuel BS, Rovera G, Nowell PC, Croce CM . A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia Proc Natl Acad Sci USA 1984 81: 7166–7170
Rosenfeld C, Goutner A, Choquet C, Venuat AM, Kayibanda B, Pico JL, Greaves MF . Phenotypic characterisation of a unique non-T, non-B acute lymphoblastic leukaemia cell line Nature 1977 267: 841–843
Manabe A, Coustan-Smith E, Kumagai M, Behm FG, Raimondi SC, Pui CH, Campana D . Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia Blood 1994 83: 1731–1737
Hurwitz R, Hozier J, LeBien T, Minowada J, Gajl-Peczalska K, Kubonishi I, Kersey J . Characterization of a leukemic cell line of the pre-B phenotype Int J Cancer 1979 23: 174–180
Minowada J, Onuma T, Moore GE . Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes J Natl Cancer Inst 1972 49: 891–895
Foley GE, Lazarus H . The response in vitro, of continuous cultures of human lymphoblasts (CCRF-CEM cells) to chemotherapeutic agents Biochem Pharmacol 1967 16: 659–674
Harmon JM, Norman MR, Fowlkes BJ, Thompson EB . Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line J Cell Physiol 1979 98: 267–278
Clark SS, McLaughlin J, Timmons M, Pendergast AM, Ben-Neriah Y, Dow LW, Crist W, Rovera G, Smith SD, Witte ON . Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL) Science 1988 239: 775–777
Beck WT, Mueller TJ, Tanzer LR . Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts Cancer Res 1979 39: 2070–2076
Danks MK, Yalowich JC, Beck WT . Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM-26) Cancer Res 1987 47: 1297–1301
Campana D, Manabe A, Evans WE . Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs Leukemia 1993 7: 482–488
Kumagai M, Manabe A, Pui CH, Behm FG, Raimondi SC, Hancock ML, Mahmoud H, Crist WM, Campana D . Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome J Clin Invest 1996 97: 755–760
Nishigaki H, Ito C, Manabe A, Kumagai M, Coustan-Smith E, Yanishevski Y, Behm FG, Raimondi SC, Pui CH, Campana D . Prevalence and growth characteristics of malignant stem cells in B-lineage acute lymphoblastic leukemia Blood 1997 89: 3735–3744
Ito C, Kumagai M, Manabe A, Coustan-Smith E, Raimondi SC, Behm FG, Murti KG, Rubnitz JE, Pui CH, Campana D . Hyperdiploid acute lymphoblastic leukemia with 51 to 65 chromosomes: a distinct biological entity with a marked propensity to undergo apoptosis Blood 1999 93: 315–320
Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D . Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia Blood 1992 79: 2370–2377
Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR . Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl J Exp Med 1995 182: 1545–1556
Ito C, Ribeiro RC, Behm FG, Raimondi SC, Pui CH, Campana D . Cyclosporin A induces apoptosis in childhood acute lymphoblastic leukemia cells Blood 1998 91: 1001–1007
Ito C, Evans WE, McNinch L, Coustan-Smith E, Mahmoud H, Pui CH, Campana D . Comparative cytotoxicity of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia J Clin Oncol 1996 14: 2370–2376
Schmitt CA, Rosenthal CT, Lowe SW . Genetic analysis of chemoresistance in primary murine lymphomas Nat Med 2000 6: 1029–1035
Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F . Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis) Cytometry 1997 27: 1–20
Short AD, Bian J, Ghosh TK, Waldron RT, Rybak SL, Gill DL . Intracellular Ca2+ pool content is linked to control of cell growth Proc Natl Acad Sci USA 1993 90: 4986–4990
McConkey DJ, Orrenius S . The role of calcium in the regulation of apoptosis Biochem Biophys Res Commun 1997 239: 357–366
Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery GS . Clotrimazole: a review of its antifungal activity and therapeutic efficacy Drugs 1975 9: 424–447
Ayub M, Levell MJ . The inhibition of human prostatic aromatase activity by imidazole drugs including ketoconazole and 4-hydroxyandrostenedione Biochem Pharmacol 1990 40: 1569–1575
Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P . Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture FASEB J 1992 6: 752–758
Wulff H, Miller MJ, Hansel W, Grissmer S, Cahalan MD, Chandy KG . Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant Proc Natl Acad Sci USA 2000 97: 8151–8156
Acknowledgements
This work was supported by grants RO1-CA58297 and P30-CA21765 from the National Cancer Institute and by the American Lebanese Syrian Associated Charities (ALSAC).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ito, C., Tecchio, C., Coustan-Smith, E. et al. The antifungal antibiotic clotrimazole alters calcium homeostasis of leukemic lymphoblasts and induces apoptosis. Leukemia 16, 1344–1352 (2002). https://doi.org/10.1038/sj.leu.2402510
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402510
Keywords
This article is cited by
-
Yeast caspase-dependent apoptosis in Saccharomyces cerevisiae BY4742 induced by antifungal and potential antitumor agent clotrimazole
Archives of Microbiology (2018)
-
Analysis of the cytotoxic effects of ruthenium–ketoconazole and ruthenium–clotrimazole complexes on cancer cells
Cell Biology and Toxicology (2013)
-
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
Leukemia (2004)